高级检索
当前位置: 首页 > 详情页

Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [2]Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China [3]Department of Urology, West China Hospital of Sichuan University, Chengdu, China [4]Department of Neonatology, West China Guang’an Hospital, Sichuan University, Guang’an, China [5]Zhengzhou Key Laboratory for Chronic Respiratory Disease, Zhengzhou, China [6]Henan Provincial Respiratory Medicine Center, Zhengzhou, China [7]The First Clinical Medical College of Lanzhou University, Lanzhou, China [8]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
出处:
ISSN:

关键词: pulmonary mucinous epidermoid carcinoma clinical characteristics prognosis Surveillance Epidemiology and End Results (SEER) nomogram

摘要:
Primary pulmonary mucoepidermoid carcinoma (PMEC) is an extremely rare malignancy. Its clinical characteristics and prognosis are not fully understood. This study evaluated clinical characteristics and prognostic factors of PMEC and established a nomogram to predict its 1-, 3-, 5- and 10-year cancer-specific survival (CSS) rates. In the Surveillance, Epidemiology, and End Results database from January 1, 2016 to December 31, 2016, patients pathologically diagnosed with PMEC were identified. Kaplan-Meier analysis and Cox regression were performed to evaluate the CSS stratified by different covariates. A predictive nomogram model was built and validated by the concordance index (C-index) and calibration curves. A total of 585 PMEC patients were identified. A total of 408 (70%) of patients were placed into the training cohort, and 177 (30%) patients were placed into the validation cohort. The 5- and 10-year CSS rates of stage I-II PMEC patients were 91.4 and 88.9, respectively. The 1-, 3- and 5-year CSS rates of stage III-IV PMEC were 56.5, 39.45, and 32.1%, respectively. Survival curves showed that older age, large tumor size, poor differentiation, and high TNM stage were associated with a significantly worse prognosis. CSS outcomes were significantly better in patients who received surgical treatments (surgical alone, surgery plus radiation and/or chemotherapy). Patients who received radiation and/or chemotherapy had the worst prognosis. Multivariate Cox results revealed that covariates, including age, tumor laterality, tumor sizes, pathological differentiation, lymph node metastasis, distant metastasis, TNM stage and therapy, were independent prognostic factors for PMEC. These factors were used to construct a nomogram. The C-index of the nomogram was 0.921. The calibration curve presented favorable consistency between the predicted CSS and actual observations. This nomogram was validated by the validation cohort. The C-index of the validation cohort was 0.968. Age, bilateral tumors, tumor size, pathological differentiation grade, lymph node metastasis, distant metastasis, TNM stage and therapy were independent prognostic factors of PMEC patients. The first nomogram for predicting the CSS of PMEC was built and validated, showing its potential value in practice. Copyright © 2021 Qiu, Song, Chen, Wang, Li, Shu, Gong, Song, Huang, Jia, Li and Zhang.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
第一作者:
第一作者机构: [1]Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [2]Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [5]Zhengzhou Key Laboratory for Chronic Respiratory Disease, Zhengzhou, China [6]Henan Provincial Respiratory Medicine Center, Zhengzhou, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43370 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号